Dystrophin quantification and clinical correlations in Becker muscular dystrophy: implications for clinical trials-Reference-Cited by-同舟云学术

Dystrophin quantification and clinical correlations in Becker muscular dystrophy: implications for clinical trials

Published:2011-11-18 Issue:12 Volume:134 Page:3547-3559
ISSN:1460-2156
Container-title:Brain
language:en
Short-container-title:

Author:

Anthony Karen¹,Cirak Sebahattin¹,Torelli Silvia¹,Tasca Giorgio²,Feng Lucy¹,Arechavala-Gomeza Virginia¹,Armaroli Annarita³,Guglieri Michela⁴,Straathof Chiara S.⁵,Verschuuren Jan J.⁵,Aartsma-Rus Annemieke⁶,Helderman-van den Enden Paula⁶,Bushby Katherine⁴,Straub Volker⁴,Sewry Caroline¹,Ferlini Alessandra³,Ricci Enzo⁷,Morgan Jennifer E.¹,Muntoni Francesco¹

Affiliation:

1. 1 The Dubowitz Neuromuscular Centre, UCL, Institute of Child Health, London WC1N 1EH, UK

2. 2 Don Carlo Gnocchi Onlus Foundation, 20148, Italy

3. 3 Section of Medical Genetics, Department of Experimental and Diagnostic Medicine, University of Ferrara, Ferrara 44100 Italy

4. 4 Institute of Genetic Medicine, Newcastle University, Newcastle NE1 3BZ, UK

5. 5 Department of Neurology, Leiden University Medical Centre, 2300 RC Leiden, The Netherlands

6. 6 Department of Human Genetics, Leiden University Medical Centre, 2300 RC Leiden, The Netherlands

7. 7 Institute of Neurology, Catholic University, Rome 00168, Italy

Funder

Wellcome Trust

Publisher

Oxford University Press (OUP)

Subject

Clinical Neurology

Link

http://academic.oup.com/brain/article-pdf/134/12/3547/28540215/awr291.pdf

Reference54 articles.

1. Theoretic applicability of antisense-mediated exon skipping for Duchenne muscular dystrophy mutations;Aartsma-Rus;Hum Mutat,2009

2. Best practice guidelines on molecular diagnostics in Duchenne/Becker muscular dystrophies;Abbs;Neuromuscul Disord,2010

3. Immunohistological intensity measurements as a tool to assess sarcolemma-associated protein expression;Arechavala-Gomeza;Neuropathol Appl Neurobiol,2010

4. Revertant fibres and dystrophin traces in Duchenne muscular dystrophy: implication for clinical trials;Arechavala-Gomeza;Neuromuscul Disord,2010

5. Exploring the molecular basis for variability among patients with Becker muscular dystrophy: dystrophin gene and protein studies;Beggs;Am J Hum Genet,1991

Cited by 122 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pig models for translational Duchenne muscular dystrophy research;Trends in Molecular Medicine;2024-05

2. Between hope and reality: treatment of genetic diseases through nucleic acid-based drugs;Communications Biology;2024-04-23

3. Characterization of Phenotypic Variability in Becker Muscular Dystrophy for Clinical Practice and Towards Trial Readiness: A Two-Years Follow up Study;Journal of Neuromuscular Diseases;2024-03-05

4. Diverse Cardiac Phenotype of Becker Muscular Dystrophy: Under-Recognized Subclinical Cardiomyopathy Due to Partial Dystrophin Deficiency in a Contemporary Era;Pediatric Cardiology;2024-01-19

5. DMD deletions underlining mild dystrophinopathies: literature review highlights phenotype-related mutation clusters and provides insights about genetic mechanisms and prognosis;Frontiers in Neurology;2024-01-15